HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $826,781 | -11.2% | 802,700 | 0.0% | 0.02% | +5.9% |
Q2 2023 | $931,132 | -23.2% | 802,700 | 0.0% | 0.02% | -29.2% |
Q1 2023 | $1,212,077 | -74.4% | 802,700 | -28.5% | 0.02% | -72.7% |
Q3 2022 | $4,739,000 | -81.2% | 1,123,000 | -5.8% | 0.09% | -60.2% |
Q4 2020 | $25,225,000 | +42.8% | 1,191,846 | 0.0% | 0.22% | -0.5% |
Q3 2020 | $17,663,000 | +81.8% | 1,191,846 | +80.5% | 0.22% | +62.0% |
Q2 2020 | $9,715,000 | +54.0% | 660,420 | +22.9% | 0.14% | +29.2% |
Q1 2020 | $6,309,000 | -75.9% | 537,420 | -49.7% | 0.11% | -73.8% |
Q1 2019 | $26,126,000 | -28.1% | 1,069,000 | -23.7% | 0.40% | -39.9% |
Q4 2018 | $36,324,000 | -24.2% | 1,400,300 | -7.5% | 0.67% | +16.5% |
Q3 2018 | $47,934,000 | -6.2% | 1,514,500 | +15.2% | 0.58% | -5.3% |
Q2 2018 | $51,092,000 | +62.4% | 1,315,100 | +15.4% | 0.61% | +56.2% |
Q1 2018 | $31,458,000 | +167.4% | 1,139,800 | +75.4% | 0.39% | +161.7% |
Q4 2017 | $11,765,000 | +12.1% | 650,000 | 0.0% | 0.15% | +49.0% |
Q3 2017 | $10,498,000 | +16.6% | 650,000 | 0.0% | 0.10% | +6.4% |
Q2 2017 | $9,003,000 | -7.7% | 650,000 | 0.0% | 0.09% | -15.3% |
Q1 2017 | $9,750,000 | – | 650,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |